Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
22854 | 366 | 36.9 | 65% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
144 | 3 | ENDOCRINOLOGY & METABOLISM//PITUITARY ADENOMA//GROWTH HORMONE | 64198 |
1175 | 2 | PROLACTIN//PROLACTIN RECEPTOR//MACROPROLACTIN | 9333 |
22854 | 1 | BROMOCRIPTINE QR//CLIN MULTIIMAGEM//LEUCOPYROKININ | 366 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BROMOCRIPTINE QR | authKW | 187714 | 1% | 75% | 3 |
2 | CLIN MULTIIMAGEM | address | 166858 | 1% | 100% | 2 |
3 | LEUCOPYROKININ | authKW | 111238 | 1% | 67% | 2 |
4 | METAB REGULAT GRP | address | 111238 | 1% | 67% | 2 |
5 | BROMOCRIPTINE | authKW | 98094 | 8% | 4% | 30 |
6 | 2 8 LEUCOPYROKININ | authKW | 83429 | 0% | 100% | 1 |
7 | ADIPOSITY DYSFUNCTION | authKW | 83429 | 0% | 100% | 1 |
8 | ANDROGENIC HORMONES AND OBESITY | authKW | 83429 | 0% | 100% | 1 |
9 | ANKK1 DRD2 TAQ1A | authKW | 83429 | 0% | 100% | 1 |
10 | ANTINOCICEPTIVE EFFECTS OF LEUCOPYROKININ ANALOGUES | authKW | 83429 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 6582 | 51% | 0% | 188 |
2 | Pharmacology & Pharmacy | 93 | 12% | 0% | 43 |
3 | Physiology | 88 | 6% | 0% | 23 |
4 | Medicine, Research & Experimental | 62 | 6% | 0% | 22 |
5 | Neurosciences | 53 | 10% | 0% | 35 |
6 | Cardiac & Cardiovascular System | 31 | 5% | 0% | 18 |
7 | Nutrition & Dietetics | 23 | 3% | 0% | 10 |
8 | Peripheral Vascular Diseases | 21 | 3% | 0% | 11 |
9 | Behavioral Sciences | 15 | 2% | 0% | 7 |
10 | Medicine, General & Internal | 9 | 4% | 0% | 15 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CLIN MULTIIMAGEM | 166858 | 1% | 100% | 2 |
2 | METAB REGULAT GRP | 111238 | 1% | 67% | 2 |
3 | CHAIR BASIC MED SCI | 83429 | 0% | 100% | 1 |
4 | DIABET METAB DIS HELMHOLZ MUNICH | 83429 | 0% | 100% | 1 |
5 | DIAGNOST AMERICA SA | 83429 | 0% | 100% | 1 |
6 | ENDOCRINOL MED HLTH SCI ENDOCRINO | 83429 | 0% | 100% | 1 |
7 | ENDOCRINOL METAB DIS C4 83 | 83429 | 0% | 100% | 1 |
8 | EQUIPE HOMEOSTASIE ENERGET REGULAT NERVEUSES | 83429 | 0% | 100% | 1 |
9 | FOOD NUTR NAT SCI | 83429 | 0% | 100% | 1 |
10 | GEN VASCULARY TRANSPLANT SURG | 83429 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PITUITARY | 9906 | 2% | 1% | 9 |
2 | HORMONE AND METABOLIC RESEARCH | 3801 | 5% | 0% | 17 |
3 | NEUROENDOCRINOLOGY | 2629 | 3% | 0% | 12 |
4 | HOMEOSTASIS IN HEALTH AND DISEASE | 2497 | 1% | 1% | 3 |
5 | CLINICAL ENDOCRINOLOGY | 1867 | 4% | 0% | 13 |
6 | EUROPEAN JOURNAL OF CARDIOLOGY | 1125 | 0% | 1% | 1 |
7 | ARCHIVES OF ENDOCRINOLOGY METABOLISM | 1054 | 0% | 1% | 1 |
8 | ENDOCRINE | 946 | 2% | 0% | 6 |
9 | DIABETES OBESITY & METABOLISM | 939 | 1% | 0% | 5 |
10 | MEDICAL SCIENCE RESEARCH-BIOCHEMISTRY | 884 | 1% | 1% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | PALA, NA , LAWAY, BA , MISGAR, RA , DAR, RA , (2015) METABOLIC ABNORMALITIES IN PATIENTS WITH PROLACTINOMA: RESPONSE TO TREATMENT WITH CABERGOLINE.DIABETOLOGY & METABOLIC SYNDROME. VOL. 7. ISSUE . P. - | 29 | 85% | 3 |
2 | VICCHI, FL , LUQUE, GM , BRIE, B , NOGUEIRA, JP , TORNADU, IG , BECU-VILLALOBOS, D , (2016) DOPAMINERGIC DRUGS IN TYPE 2 DIABETES AND GLUCOSE HOMEOSTASIS.PHARMACOLOGICAL RESEARCH. VOL. 109. ISSUE . P. 74 -80 | 38 | 45% | 2 |
3 | LAMOS, EM , LEVITT, DL , MUNIR, KM , (2016) A REVIEW OF DOPAMINE AGONIST THERAPY IN TYPE 2 DIABETES AND EFFECTS ON CARDIO-METABOLIC PARAMETERS.PRIMARY CARE DIABETES. VOL. 10. ISSUE 1. P. 60 -65 | 20 | 80% | 1 |
4 | INANCLI, SS , USLUOGULLARI, A , USTU, Y , CANER, S , TAM, AA , ERSOY, R , CAKIR, B , (2013) EFFECT OF CABERGOLINE ON INSULIN SENSITIVITY, INFLAMMATION, AND CAROTID INTIMA MEDIA THICKNESS IN PATIENTS WITH PROLACTINOMA.ENDOCRINE. VOL. 44. ISSUE 1. P. 193-199 | 22 | 76% | 11 |
5 | AURIEMMA, RS , GRANIERI, L , GALDIERO, M , SIMEOLI, C , PERONE, Y , VITALE, P , PIVONELLO, C , NEGRI, M , MANNARINO, T , GIORDANO, C , ET AL (2013) EFFECT OF CABERGOLINE ON METABOLISM IN PROLACTINOMAS.NEUROENDOCRINOLOGY. VOL. 98. ISSUE 4. P. 299-310 | 35 | 48% | 10 |
6 | CIRESI, A , AMATO, MC , GUARNOTTA, V , LO CASTRO, F , GIORDANO, C , (2013) HIGHER DOSES OF CABERGOLINE FURTHER IMPROVE METABOLIC PARAMETERS IN PATIENTS WITH PROLACTINOMA REGARDLESS OF THE DEGREE OF REDUCTION IN PROLACTIN LEVELS.CLINICAL ENDOCRINOLOGY. VOL. 79. ISSUE 6. P. 845 -852 | 22 | 61% | 18 |
7 | MIKHAIL, N , (2011) QUICK-RELEASE BROMOCRIPTINE FOR TREATMENT OF TYPE 2 DIABETES.CURRENT DRUG DELIVERY. VOL. 8. ISSUE 5. P. 511-516 | 16 | 94% | 4 |
8 | CARRE, N , BINART, N , (2014) PROLACTIN AND ADIPOSE TISSUE.BIOCHIMIE. VOL. 97. ISSUE . P. 16-21 | 22 | 48% | 15 |
9 | SCHWARTZ, SS , ZANGENEH, F , (2016) EVIDENCE-BASED PRACTICE USE OF QUICK-RELEASE BROMOCRIPTINE ACROSS THE NATURAL HISTORY OF TYPE 2 DIABETES MELLITUS.POSTGRADUATE MEDICINE. VOL. 128. ISSUE 8. P. 828 -838 | 27 | 42% | 0 |
10 | TUZCU, A , YALAKI, S , ARIKAN, S , GOKALP, D , BAHCEC, M , TUZCU, S , (2009) EVALUATION OF INSULIN SENSITIVITY IN HYPERPROLACTINEMIC SUBJECTS BY EUGLYCEMIC HYPERINSULINEMIC CLAMP TECHNIQUE.PITUITARY. VOL. 12. ISSUE 4. P. 330 -334 | 18 | 69% | 15 |
Classes with closest relation at Level 1 |